[go: up one dir, main page]

NZ336321A - Use of benzothiophene (raloxifene) for treating breast cancer - Google Patents

Use of benzothiophene (raloxifene) for treating breast cancer

Info

Publication number
NZ336321A
NZ336321A NZ336321A NZ33632199A NZ336321A NZ 336321 A NZ336321 A NZ 336321A NZ 336321 A NZ336321 A NZ 336321A NZ 33632199 A NZ33632199 A NZ 33632199A NZ 336321 A NZ336321 A NZ 336321A
Authority
NZ
New Zealand
Prior art keywords
breast cancer
raloxifene
benzothiophene
treating breast
medicament
Prior art date
Application number
NZ336321A
Inventor
Frederic Jay Cohen
Joan Ellen Glusman
Ronald Keith Knickerbocker
Teri Janine Scott
Nikolaus Thomas Nickelsen
Robert Stephen Eckert
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9624800.0A external-priority patent/GB9624800D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ336321A publication Critical patent/NZ336321A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Use of a compound of Formula (I) as a medicament for preventing invasive breast cancer. The medicament may be administered at a concentration of 30-200mg/day, preferably 60mg/day.
NZ336321A 1996-10-30 1999-06-16 Use of benzothiophene (raloxifene) for treating breast cancer NZ336321A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2985096P 1996-10-30 1996-10-30
GBGB9624800.0A GB9624800D0 (en) 1996-11-29 1996-11-29 Methods of preventing breast cancer
US4026097P 1997-03-10 1997-03-10
NZ32904299 1999-06-16

Publications (1)

Publication Number Publication Date
NZ336321A true NZ336321A (en) 2000-11-24

Family

ID=27451565

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ336321A NZ336321A (en) 1996-10-30 1999-06-16 Use of benzothiophene (raloxifene) for treating breast cancer

Country Status (1)

Country Link
NZ (1) NZ336321A (en)

Similar Documents

Publication Publication Date Title
MX9700885A (en) New heteroaryloxazolidinones.
AU5624699A (en) Use of 5ht-6 antagonists
MD1616G2 (en) Tricyclic compounds and method of inhibiting the tyrasin kinases receptors of the epidermal growth factor, pharmaceutical composition, methods of preventing the blastocites implantation and mammals treatment
TR200000129T2 (en) Brand new spiroazabicyclic heterocyclic compounds.
MY137348A (en) Highly selective norepinephrine reuptake inhibitors and methods of using the same
ZA975437B (en) New pyridyl alkene and pyridyl alkine acid amides.
RU2011138835A (en) APPLICATION OF DERIVATIVE RAMAPICIN
MY119403A (en) Novel compounds with analgesic effect.
AU3850600A (en) Dalda analogs and their use
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
SE9903997D0 (en) New compounds
SE9802208D0 (en) Novel compounds
DE69907419D1 (en) Antitumorwirkstoffe
ES2135342A1 (en) Improvements in or relating to the prophylaxis of breast cancer by the administration of raloxifene
AP2002002387A0 (en) Method of inhibiting amyloid aggregation and imaging amyloid deposits.
RU94044489A (en) Use of 2-phenyl-3-aroylbenzothiophenes for myeloperoxidase activity inhibition
RU94044356A (en) Use of 2-phenyl-3-aroylbenzothiophenes for thrombodulin expression increase to inhibit thrombotic disorder, for protein c activation
IL126235A0 (en) Compounds with growth hormone releasing properties
RU94045271A (en) Use of 2-phenyl-3-aroylbenzothiophenes for terner's syndrome inhibition
RU94045156A (en) Use of 2-phenyl-3-aroylbenzothiophenes for premature sexual maturation inhibition
NZ336321A (en) Use of benzothiophene (raloxifene) for treating breast cancer
YU46302A (en) Substituted pyrroles
AU4944899A (en) New pharmaceutically active compounds
WO2000010543A3 (en) Medicament containing platinum complex compounds and the use thereof
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: ELI LILLY AND COMPANY, US

Free format text: OLD OWNER(S): ELI LILLY AND COMPANY; DRAPER, MICHAEL WILLIAM

S883 Correction of error according to section 88(3) (mistake in register caused on part of patentee or applicant)

Free format text: CORRECTION TO INVENTOR (72)

EXPY Patent expired